Back to Search Start Over

Body mass index is inversely associated with capillary ketones at the time of colonoscopy: Implications for SGLT2i use.

Authors :
Hamblin, Peter S.
Wong, Rosemary
Ekinci, Elif I.
Sztal‐Mazer, Shoshana
Balachandran, Shananthan
Frydman, Aviva
Hanrahan, Timothy P.
Hu, Raymond
Ket, Shara N.
Moss, Alan
Ng, Mark
Ragunathan, Sashikala
Bach, Leon A.
Source :
Clinical Endocrinology; Apr2022, Vol. 96 Issue 4, p549-557, 9p
Publication Year :
2022

Abstract

Objective: Sodium–glucose cotransporter 2 inhibitors (SGLT2i) have been associated with diabetic ketoacidosis at the time of colonoscopy. This study aimed to identify factors associated with ketone concentrations in SGLT2i‐treated type 2 diabetes compared with non‐SGLT2i‐treated diabetes, and those with impaired fasting glycaemia (IFG) and normoglycaemia. Design: Cross‐sectional, multicentre, observational study June–December 2020 in four Australian tertiary hospitals. Participants: Capillary glucose and ketones were measured in people undergoing colonoscopy: 37 SGLT2i‐treated and 105 non‐SGLT2i‐treated type 2 diabetes, 65 IFG and 151 normoglycaemia. Measurements: Body mass index (BMI), age, glucose, fasting duration and where relevant, HbA1c and time since last SGLT2i dose. Results: In SGLT2i‐treated diabetes, BMI (ρ = −0.43 [95% confidence interval: −0.67, −0.11]) and duration since last SGLT2i dose (ρ = −0.33 [−0.60, 0.00]) correlated negatively with increasing ketones, but there was no correlation with fasting duration. In non‐SGLT2i‐treated diabetes, BMI correlated negatively (ρ = −0.24 [−0.42, −0.05]) and fasting duration positively (ρ = 0.26 [0.07, 0.43]) with ketones. In IFG participants, only fasting duration correlated with ketones (ρ = 0.28 [0.03, 0.49]). In normoglycaemic participants, there were negative correlations with BMI (ρ = −0.20 [−0.35, −0.04]) and fasting glucose (ρ = −0.31 [−0.45, −0.15]) and positive correlations with fasting duration (ρ = 0.20 [0.04, 0.35]) and age (ρ = 0.19 [0.03, 0.34]). Multiple regression analysis of the entire cohort showed BMI, age and fasting glucose remained independently associated with ketones, but in SGLT2i‐treated participants only BMI remained independently associated. Conclusions: In SGLT2i‐treated diabetes, lower BMI was a novel risk factor for higher ketones precolonoscopy. Pending larger confirmatory studies, extra vigilance for ketoacidosis is warranted in these people. [ABSTRACT FROM AUTHOR]

Details

Language :
English
ISSN :
03000664
Volume :
96
Issue :
4
Database :
Complementary Index
Journal :
Clinical Endocrinology
Publication Type :
Academic Journal
Accession number :
155658340
Full Text :
https://doi.org/10.1111/cen.14621